Serpin B-2 (Recombinant)
- Expression system
- HEK293
- Cat. #
- REC-SerpinB2
In stock
- SKU
- REC-SerpinB2
Target Overview
Serpin B-2 (PAI-2; SERPINB2; UniProt P05120) is a 415-amino-acid serine protease inhibitor of the clade B (ov-serpin) family. Unlike the endothelial cell-derived PAI-1 (SERPINE1), PAI-2 is primarily expressed in monocytes and placental tissue and functions as a physiological inhibitor of urokinase-type plasminogen activator (uPA). Its canonical mechanism involves formation of a stable, covalent acyl-enzyme complex with the active-site serine of uPA, thereby attenuating plasminogen activation and downstream fibrinolysis. PAI-2 is also constitutively cytoplasmic in many cell types, where a non-inhibitory pool has been implicated in keratinocyte differentiation and intracellular scaffolding functions that are independent of protease inhibition. This recombinant is produced in HEK293 cells, providing mammalian post-translational processing appropriate for structural and functional studies of the native inhibitor. HEK293 expression is particularly relevant for PAI-2 because the protein is known to form non-covalently associated dimers and higher-order polymers whose assembly is sensitive to the folding environment; prokaryotic expression often produces inclusion bodies that require refolding. In the laboratory, this recombinant serves multiple purposes: as an active inhibitor standard in chromogenic or fluorogenic uPA activity assays, as a competition reagent in inhibitor IC50 determinations, and as a positive-control antigen in Western blot and ELISA validation experiments. Researchers validating anti-SERPINB2 antibodies can pair this recombinant directly with the matched Triple Point Biologics antibody (RP-SerpinB2) to confirm band identity, optimize loading, and establish signal linearity. Its defined sequence and mammalian glycosylation profile also make it suitable as a reference standard in quantitative proteomic workflows.
Background
Applications
- Urokinase-type plasminogen activator (uPA) inhibition assay — determination of inhibitory rate constant (k_ass) and stoichiometry of inhibition
- Fibrinolytic activity assay — recombinant PAI-2 used as a defined inhibitor standard alongside tPA and uPA in chromogenic plasminogen activation cascades
- Inhibitor IC50 / competition screen — titration of PAI-2 against uPA in fluorogenic substrate (e.g., Boc-Glu-Gly-Arg-AMC) format to benchmark test compounds
- Antibody validation positive control — paired with matched Triple Point Biologics antibody RP-SerpinB2 for Western blot band identification and ELISA signal calibration
- Quantitative ELISA standard curve — serial dilution of recombinant PAI-2 for absolute quantification of endogenous SERPINB2 in cell lysates or conditioned media
- Surface plasmon resonance (SPR) or biolayer interferometry (BLI) — immobilised PAI-2 for binding kinetics of anti-SERPINB2 antibodies or candidate small-molecule ligands
- Serpin polymerisation / conformational study — mammalian-expressed PAI-2 as a substrate for native PAGE, SEC-MALS, or cryo-EM investigation of dimer and polymer assembly
References
- Zhu Y et al. Epithelial SERPINB2 Overexpression Contributes to Impaired Fibrinolysis in Chronic Rhinosinusitis With Nasal Polyps via tPA Downregulation. Front Biosci (Landmark Ed). 2026. doi:10.31083/FBL50406. PMID: 42216541
- Collado-Cuadrado M et al. Proteomic Analysis of Endothelial Activation Induced by Adult Angiostrongylus vasorum Homogenate: Insights into Vascular Remodeling and Hemostatic Imbalance. Animals (Basel). 2026. doi:10.3390/ani16060926. PMID: 41897903
- Nie Q et al. Neuro-immune-related gene signatures define molecular subtypes and prognostic score in bladder cancer with SERPINE2 as a potential therapeutic target. PeerJ. 2026. doi:10.7717/peerj.20917. PMID: 41800135
- Bhat V et al. Gene expression profiling identifies potential biomarkers for vaso-occlusive episodes in sickle cell disease. JCI Insight. 2026. doi:10.1172/jci.insight.193359. PMID: 41797711
- Chen L et al. Identification of Novel Biomarkers for Crohn's Disease Through the Integration of Machine Learning, Colocalization, and SMR Analysis. FASEB J. 2026. doi:10.1096/fj.202504792R. PMID: 41773807
Additional Specifications
| Storage Buffer | 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol |
|---|---|
| Endotoxin Level | <0.1 EU/µg by LAL |
| Purity (%) | >90% by SDS-PAGE |
| Expression System | HEK293 |
| Subcellular Localization | Secreted; blood plasma |
Frequently Asked Questions
What molecular weight should I expect for recombinant Serpin B-2 on SDS-PAGE and Western blot?
Recombinant Serpin B-2 (PAI-2; P05120) runs at approximately 47–50 kDa under reducing SDS-PAGE conditions, slightly above its calculated molecular weight of ~45 kDa for the 415-amino-acid sequence. The upward shift is typical for this protein and reflects its glycosylation profile, which is preserved in the HEK293 expression system used here. Under non-reducing conditions a minor high-molecular-weight smear can appear due to intermolecular disulfide-linked species. Purity is >95% by SDS-PAGE. If you are running a Western blot positive control alongside RP-SerpinB2 antibody, load this band as your reference.
Does this recombinant Serpin B-2 correspond to the glycosylated or non-glycosylated isoform of PAI-2?
PAI-2 (SERPINB2) is naturally expressed in two forms: a non-glycosylated intracellular form (~47 kDa) and a secreted, N-glycosylated form (~60 kDa). This recombinant is produced in HEK293 cells with a secretion signal, yielding the glycosylated, secreted-equivalent form that migrates at ~47–50 kDa under our expression conditions. Full 60 kDa glycosylation seen in some primary placental sources is not always recapitulated at equivalent density in HEK293; if your assay is sensitive to glycan composition, PNGase F digestion of a test aliquot before use is advisable for confirmation.
What protease does recombinant Serpin B-2 inhibit and what is the preferred substrate for an activity assay?
Serpin B-2 (PAI-2) is a physiological inhibitor of urokinase-type plasminogen activator (uPA; PLAU). In a functional inhibition assay, incubate recombinant PAI-2 with two-chain uPA, then monitor residual uPA amidolytic activity using the chromogenic substrate Spectrozyme UK (H-D-Glu-Gly-Arg-pNA·2HCl) or the equivalent Boc-Glu-Gly-Arg-AMC fluorogenic substrate at 0.2–0.5 mM in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.01% Tween-20. PAI-2 forms a covalent acyl-enzyme complex with uPA's active-site Ser195, providing a clean endpoint for stoichiometric inhibition studies. Tissue-type plasminogen activator (tPA) inhibition is roughly 10-fold weaker and not the recommended primary readout.
What starting concentration of recombinant Serpin B-2 should I use for a uPA inhibition assay and how does IC50 vary with uPA concentration?
Because PAI-2 is a stoichiometric, covalent inhibitor rather than a classical competitive inhibitor, IC50 is not a fixed intrinsic constant — it scales linearly with uPA concentration (a consequence of tight-binding inhibition kinetics). As a practical starting point, use 50–200 nM recombinant PAI-2 paired with 10–50 nM two-chain uPA in assay buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.01% Tween-20, 37 °C). Titrate PAI-2 from 0.1× to 5× the uPA molar concentration to bracket the inhibition curve. For second-order rate constant (k2) determinations, pseudo-first-order conditions with a ≥10-fold molar excess of PAI-2 over uPA are standard.
What buffer conditions are optimal for storing and diluting recombinant Serpin B-2 before assay?
The supplied storage buffer is 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol. Aliquots are stable at −20 °C for at least 12 months; avoid repeated freeze-thaw cycles, as serpins are susceptible to latency conversion (loop insertion without cleavage) upon thermal cycling. For assay dilutions, exchange into or dilute into the same Tris-NaCl buffer minus glycerol, adding 0.01–0.05% Tween-20 or 0.1% BSA as a carrier to prevent surface adsorption at sub-nanomolar concentrations. Do not dilute into phosphate buffers below pH 7.0, as serpin conformation is pH-sensitive in the 6.5–7.0 range.
Can I use recombinant Serpin B-2 as a positive control for Western blot with the RP-SerpinB2 rabbit polyclonal antibody?
Yes — this is the primary intended cross-use case. Recombinant Serpin B-2 (REC-SerpinB2) and the matched rabbit polyclonal antibody (RP-SerpinB2) are developed from the same lab and validated together for Western blot. Load 20–50 ng of recombinant protein per lane alongside your cell lysate lanes; under standard reducing SDS-PAGE you will see a clean ~47–50 kDa band that serves as an unambiguous size and signal reference. The matched antibody page is at /anti-serpin-b2-rabbit-polyclonal-antibody. This pairing is particularly useful when validating antibody lot-to-lot consistency or when establishing detection sensitivity in new cell line lysates.
How much recombinant Serpin B-2 should I load for a Western blot positive control, and what dilution of RP-SerpinB2 antibody should I use?
Load 20–50 ng of REC-SerpinB2 per lane for a positive control band. At this amount, RP-SerpinB2 rabbit polyclonal antibody (SKU: RP-SerpinB2) typically performs well at a primary antibody dilution of 1:1,000–1:2,000 in 5% non-fat milk/TBST with a 1-hour room-temperature or overnight 4 °C incubation. For high-sensitivity detection (e.g., ECL plus or fluorescent secondary), 10–20 ng may be sufficient and will reduce background. Always run the recombinant in a lane separate from the highest-concentration lysate to avoid signal bleed-over distorting band interpretation.
How do I reconstitute or dilute recombinant Serpin B-2 from a frozen stock without losing activity?
Aliquots are supplied ready-to-use in solution (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol) — no lyophilization step is required. Thaw a single-use aliquot on ice (10–15 minutes), briefly spin at 10,000 × g for 30 seconds to collect any condensate, then dilute directly into your assay buffer. Avoid vortexing; serpins can partially unfold under shear. If working at concentrations below 10 nM, add 0.1% BSA or 0.05% Tween-20 to prevent adsorptive loss to tube walls. Discard unused diluted material; do not refreeze working dilutions. Opened stock vials can be held at 4 °C for up to 7 days without significant activity loss.
Validation imagery coming soon
Western blot validation figures for REC-SerpinB2 will be published here as they are produced in-house.
If you would like to see existing validation data for this antibody before publication, request a sample copy.